[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2001034769A3 - 24 human secreted proteins - Google Patents

24 human secreted proteins Download PDF

Info

Publication number
WO2001034769A3
WO2001034769A3 PCT/US2000/030040 US0030040W WO0134769A3 WO 2001034769 A3 WO2001034769 A3 WO 2001034769A3 US 0030040 W US0030040 W US 0030040W WO 0134769 A3 WO0134769 A3 WO 0134769A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
human secreted
proteins
novel human
relates
Prior art date
Application number
PCT/US2000/030040
Other languages
French (fr)
Other versions
WO2001034769A2 (en
Inventor
Steven M Ruben
George A Komatsoulis
Ping Wei
Kevin P Baker
Michele Fiscella
Original Assignee
Human Genome Sciences Inc
Steven M Ruben
George A Komatsoulis
Ping Wei
Kevin P Baker
Michele Fiscella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Steven M Ruben, George A Komatsoulis, Ping Wei, Kevin P Baker, Michele Fiscella filed Critical Human Genome Sciences Inc
Priority to EP00978315A priority Critical patent/EP1235845A4/en
Priority to JP2001537466A priority patent/JP2003513663A/en
Priority to CA002388019A priority patent/CA2388019A1/en
Priority to AU15789/01A priority patent/AU1578901A/en
Publication of WO2001034769A2 publication Critical patent/WO2001034769A2/en
Publication of WO2001034769A3 publication Critical patent/WO2001034769A3/en
Priority to US12/198,817 priority patent/US7968689B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
PCT/US2000/030040 1997-03-07 2000-11-01 24 human secreted proteins WO2001034769A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP00978315A EP1235845A4 (en) 1999-11-05 2000-11-01 24 human secreted proteins
JP2001537466A JP2003513663A (en) 1999-11-05 2000-11-01 24 human secretory proteins
CA002388019A CA2388019A1 (en) 1999-11-05 2000-11-01 24 human secreted proteins
AU15789/01A AU1578901A (en) 1999-11-05 2000-11-01 24 human secreted proteins
US12/198,817 US7968689B2 (en) 1997-03-07 2008-08-26 Antibodies to HSDEK49 polypeptides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16358099P 1999-11-05 1999-11-05
US60/163,580 1999-11-05
US21513000P 2000-06-30 2000-06-30
US60/215,130 2000-06-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030037 Continuation-In-Part WO2001034623A1 (en) 1997-03-07 2000-11-01 29 human secreted proteins

Related Child Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2000/029364 Continuation-In-Part WO2001032687A1 (en) 1997-03-07 2000-10-25 10 human secreted proteins
PCT/US2000/029364 Continuation WO2001032687A1 (en) 1997-03-07 2000-10-25 10 human secreted proteins
US10/100,683 Continuation-In-Part US7368531B2 (en) 1997-03-07 2002-03-19 Human secreted proteins

Publications (2)

Publication Number Publication Date
WO2001034769A2 WO2001034769A2 (en) 2001-05-17
WO2001034769A3 true WO2001034769A3 (en) 2002-01-17

Family

ID=26859770

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030040 WO2001034769A2 (en) 1997-03-07 2000-11-01 24 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1235845A4 (en)
JP (1) JP2003513663A (en)
AU (1) AU1578901A (en)
CA (1) CA2388019A1 (en)
WO (1) WO2001034769A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005506844A (en) * 2001-10-22 2005-03-10 エクセリクシス・インコーポレイテッド LRRCAPS as a p53 pathway modifier and method of use
US7141381B2 (en) 2002-04-25 2006-11-28 Bristol-Myers Squibb Company Human leucine-rich repeat-containing proteins specifically expressed in the nervous system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066690A2 (en) * 2000-03-06 2001-09-13 Smithkline Beecham Corporation Novel compounds
EP2295456A1 (en) * 2000-04-12 2011-03-16 Human Genome Sciences, Inc. Albumin fusion proteins
CN1322825A (en) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 New polypeptide superoxide dismutase 11 and its encoding polynucleotides
EP1315743B1 (en) * 2000-09-08 2012-11-07 Merck Sharp & Dohme Corp. Mammalian genes; related reagents and methods

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), ROBERTSON N G, ET AL: "DF11Q08.Y1 MORTON FETAL COCHLEA HOMO SAPIENS CDNA CLONE IMAGE:2483150 5', MRNA SEQUENCE", XP002940274, Database accession no. AW020587 *
DATABASE MPSRCH GENBANK 1 January 1900 (1900-01-01), HEATH P: "HUMAN DNA SEQUENCE FROM CLONE GS1-115M3 ON CHROMOSOME XQ27.1-28, COMPLETE SEQUENCE", XP002940273, Database accession no. AL109653 *
DATABASE TREMBL PROTEIN SEQUE 1 January 1900 (1900-01-01), NAGASE T, ET AL: "KIAA0918 PROTEIN (FRAGMENT)", XP002940275, Database accession no. O94991 *
GENOMICS, vol. 23, 1994, pages 42 - 50 *
See also references of EP1235845A4 *

Also Published As

Publication number Publication date
JP2003513663A (en) 2003-04-15
CA2388019A1 (en) 2001-05-17
EP1235845A4 (en) 2003-06-25
EP1235845A2 (en) 2002-09-04
WO2001034769A2 (en) 2001-05-17
AU1578901A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
EP1053245A4 (en) 45 human secreted proteins
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
WO1998040483A3 (en) 28 human secreted proteins
WO1998031800A3 (en) Human proteins
WO2001032910A3 (en) 27 human secreted proteins
WO2001036432A3 (en) 18 human secreted proteins
WO1998045712A3 (en) 20 human secreted proteins
CY1111950T1 (en) 32 HUMAN EXTRACTED PROTEINS
WO2001012776A3 (en) 18 human secreted proteins
WO2001034768A3 (en) 15 human secreted proteins
WO2000017222A8 (en) 31 human secreted proteins
WO2000077026A8 (en) 49 human secreted proteins
WO2000052136A3 (en) Human glycosylation enzymes
WO2000063230A3 (en) 49 human secreted proteins
WO2000073323A3 (en) Adam polynucleotides and polypeptides
WO2001062891A3 (en) 207 human secreted proteins
EP1042342A4 (en) 53 human secreted proteins
WO2000058339A3 (en) 50 human secreted proteins
WO2001012775A8 (en) 25 human secreted proteins
WO2000043495A3 (en) 33 human secreted proteins
WO2000061624A8 (en) 48 human secreted proteins
WO2000061596A8 (en) 50 human secreted proteins
WO2003052377A9 (en) 41 human secreted proteins
WO2002099066A3 (en) 20 human secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2388019

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 537466

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000978315

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000978315

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000978315

Country of ref document: EP